摘要
背景:Notch通路是进化上保守的细胞间信号系统,存在于所有多细胞生物体和哺乳动物体内。 Notch途径在胚胎发育中起重要作用,因为它控制细胞增殖,细胞分化和二元细胞命运决定。 目的:在本综述中,我们强调Notch信号传导途径组分,即Notch受体,配体,效应物及其调节剂。我们还讨论了涉及各种癌症的Notch途径的肿瘤生物学。 结果:有趣的是,Notch信号通路在许多癌症中失调。 Notch可作为癌基因或抑癌基因,在肝癌,胰腺癌,子宫内膜癌,卵巢癌,前列腺癌,膀胱癌和结肠癌中发挥重要作用。 Notch途径的激活在某些癌症的发展中起着至关重要的作用。此外,Notch通路激活也被证明可以驱动癌症的化疗耐药性。化学治疗上,联合的NOTCH1抑制剂在体外和体内协同减毒富集化疗的癌症干细胞群体。这可能证明在治疗癌症方面是有益的。 结论:Notch抑制剂具有抗癌增殖作用,可作为癌症治疗的新靶点。
关键词: Notch途径,抑制剂,信号传导,癌症,治疗,胚胎发育,细胞增殖。
图形摘要
Current Drug Targets
Title:Notch Signalling Pathways and Their Importance in the Treatment of Cancers
Volume: 19 Issue: 2
关键词: Notch途径,抑制剂,信号传导,癌症,治疗,胚胎发育,细胞增殖。
摘要: Background: The Notch pathway is an evolutionarily conserved, intercellular signalling system which is present in all multicellular organisms and mammals. The Notch pathway plays an important role in the embryonic development as it controls cell proliferation, cell differentiation and binary cell fate decisions.
Objective: In the present review, we highlight the Notch signalling pathway components i.e. Notch receptors, ligands, effector, and their regulators. We also discuss the tumor biology of the Notch pathway involved in various cancers.
Results: Interestingly, the Notch signalling pathway is dysregulated in many cancers. Notch may serve as oncogene or tumor suppressor and plays an important role in cancers of the liver, pancreas, endometrium of uterus, ovary, prostate, bladder and colon. The activation of Notch pathway plays a vital role in the progression of some cancer. In addition, Notch pathway activation was also shown to drive chemoresistance in cancer, as well. Chemotherapeutically, combined NOTCH1 inhibitor synergistically attenuated chemotherapy-enriched cancer stem cell population both in vitro and in vivo. This may prove to be beneficial in the treatment of cancer.
Conclusion: The Notch inhibitors possess anti-proliferative effects on cancer, thereby serving as a new treatment for cancer.
Export Options
About this article
Cite this article as:
Notch Signalling Pathways and Their Importance in the Treatment of Cancers, Current Drug Targets 2018; 19 (2) . https://dx.doi.org/10.2174/1389450118666170309143419
DOI https://dx.doi.org/10.2174/1389450118666170309143419 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Related Journals
Related Books
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Different Generations of Type-B Monoamine Oxidase Inhibitors in Parkinson’s Disease: From Bench to Bedside
Current Neuropharmacology Functional Chemical Groups that May Likely Become a Source for the Synthesis of Novel Central Nervous System (CNS) Acting Drugs
Central Nervous System Agents in Medicinal Chemistry Notch Signaling in Cardiovascular Disease and Calcification
Current Cardiology Reviews Hepatic Effects of Duloxetine-II: Spontaneous Reports and Epidemiology of Hepatic Events
Current Drug Safety Marfan Syndrome and Related Heritable Thoracic Aortic Aneurysms and Dissections
Current Pharmaceutical Design Cholesterol Efflux and Reverse Cholesterol Transport: Experimental Approaches
Current Medicinal Chemistry Cell Death and microRNAs in Cholestatic Liver Diseases: Update on Potential Therapeutic Applications
Current Drug Targets Insight γ-Secretase: Structure, Function, and Role in Alzheimer’s Disease
Current Drug Targets Neurocognitive Monitoring and Care During Pediatric Cardiopulmonary Bypass — Current and Future Directions
Current Cardiology Reviews New Advances in the Molecular Mechanisms Driving Biliary Fibrosis and Emerging Molecular Targets
Current Drug Targets Enzymes as Target Antigens of Liver-Specific Autoimmunity: The Case of Cytochromes P450s
Current Medicinal Chemistry Current Options for Treatment of End-Stage Liver Disease in Children
Current Pediatric Reviews Notch Signaling in Normal and Disease States: Possible Therapies Related to Glycosylation
Current Molecular Medicine Clinical Efficacy and Effectiveness of Ursodeoxycholic Acid in Cholestatic Liver Diseases
Current Clinical Pharmacology Autoimmune Hepatitis: A Childhood Disease
Current Pediatric Reviews Congenital Scoliosis (Mini-review)
Current Pediatric Reviews Personalized and Regenerative Medicine for Liver Diseases
Current Stem Cell Research & Therapy Nutrition and Growth in Children with Chronic Liver Disease and After Liver Transplantation
Current Nutrition & Food Science Genetics of Congenital Heart Disease
Current Cardiology Reviews The High Mobility Group A1 (HMGA1) Transcriptome in Cancer and Development
Current Molecular Medicine